{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:34359",
      "entity_text" : "carbidopa",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:681",
      "entity_text" : "dopamine",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "In the presence of carbidopa (BBB-impermeable), a potent AAAD inhibitor that is clinically used as a codrug together with l-Dopa (referring to Scheme XREF_FIG), the build-up of dopamine was effectively suppressed (~ 85%) even at [carbidopa] = 5 mum (0.01 equiv of l-Dopa (0.5 mm)) and completely suppressed at [carbidopa] = 50 mum (0.1 equiv).",
  "reading_complete" : "2020-08-04T15:33:32Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T15:30:15Z",
  "trigger" : "suppressed",
  "evidence" : [ "dopamine was effectively suppressed (~85 %) even at [carbidopa" ],
  "pmc_id" : "4906467",
  "score" : 0
}